Myricetin (MY) is a dietary flavonoid
which exhibits a wide spectrum
of biological properties, viz., antibacterial, antioxidant, anticancer,
and so forth. The lower solubility in aqueous medium and hence lesser
bioavailability of MY limits the use of such dietary flavonoids in
further in vivo research. To overcome bioavailability limitations,
a number of drug-delivery systems are being investigated. Herein,
MY-mediated silver nanoparticles (MY-AgNPs) were synthesized by a
green approach to improve the therapeutic efficacy of MY. MY-AgNPs
were characterized by ultraviolet–visible spectroscopy (UV–Vis),
scanning electron microscopy (SEM), transmission electron microscopy
(TEM), Fourier transform infrared (FTIR) spectroscopy, and X-ray powder
diffraction (XRD). The results showed that the dispersion of AgNPs
had the maximum UV–vis absorption at about 410 nm. The synthesized
nanoparticles were almost spherical. MY-AgNPs were further investigated
against human pathogenic bacteria, and their antioxidant potential
was also determined. The free radical scavenging rate was about 60–87%.
MY-AgNPs had good antibacterial activity against
Escherichia
coli
and
Salmonella
at room temperature with minimum inhibitory concentrations of 10
–4
and 10
–5
g/L, respectively.